[at Seeking Alpha] – Last week marked the end of a two-year case involving Johnson & Johnson’s ( JNJ ) subsidiary Janssen Pharmaceuticals and the U.S. government. The case alleged that Janssen marketed antipsychotics, including …
Read more on … [visit site to read more]
- Stock Update: NIKE Inc. (NYSE:NKE) – Under Armour goes after activity tracking in a big way with acquisition of MapMyFitness
- Johnson & Johnson (NYSE:JNJ) – Is Johnson & Johnson a Buy at These Prices?
- Johnson & Johnson (NYSE:JNJ) | Johnson & Johnson Wants Extra Strength Assurance from Amazon